EC adopts proposals to improve animal and human health
The Commission has adopted proposals on veterinary medicinal products and medicated feed, to improve the health and wellbeing of animals, to tackle antimicrobial resistance (AMR) in the EU and to foster innovation.
The proposal on veterinary medicinal products aims in particular to make more medicines available in the EU to treat and prevent diseases in animals.
The proposal on the modernisation of medicated feed legislation now includes feed for pets in its scope. The idea is to ensure the appropriate standard of product quality and safety in the EU, whilst simultaneously paving the way for better treatments for diseased animals.
The proposed rules will benefit animals – including aquatic species, their holders, pet owners, veterinarians and businesses - including the pharmaceutical and feed industries, in the EU.
Tonio Borg, European Commissioner for Health, said: "These proposals both have animal health and welfare at their heart. However, they also represent a major step forward for public health as they introduce measures that contribute towards combatting the growing threat of antimicrobial resistance (AMR), keeping antibiotics effective for people and animals alike.”
Proposal on veterinary medicinal products
With its proposal, the Commission aims to tailor legislation on veterinary medicines to the needs of the veterinary sector whilst continuing to ensure a high level of public and animal health and a safe environment.
The proposed Regulation builds upon existing EU rules for veterinary medicines which ensure that only medicines that have been granted a marketing authorisation can be placed on the market. However, rules are simplified to ensure the development of suitable medicines for animals in the EU. This reduction in red tape will concern both the marketing authorisation procedure and the monitoring of side effects (pharmacovigilance).
The proposed rules are particularly timely for minor species such as bees, goats, turkeys, horses etc. for whom available medicines are currently lacking.
To combat AMR and to help keep antibiotics effective in humans and animals, the proposal introduces the possibility of restricting the authorisation and use in animals of certain antimicrobials that are reserved to treat human infections.
Proposal on medicated feed
The proposed Regulation will repeal and substitute the outdated Directive (90/167/EEC) on the manufacture, placing on the market and use of medicated feed. After veterinary prescriptions, medicated feed is an important route for administering veterinary medicines to animals. Its aim is to harmonise the production standards and marketing of medicated feed in the EU at an appropriate safety level, and to reflect technical and scientific progress in this area.
The proposed rules will ensure that medicated feed can only be manufactured from specifically authorised veterinary medicines and by approved manufacturers. AMR will be tackled through measures such as a ban on medicated feed being used preventively or as growth promoters. Additionally, EU wide residue limits for veterinary medicines in ordinary feed are established at a limit to avoid the development of AMR.
The scope of the proposal explicitly includes medicated feed for pets, so that pets – especially those with chronic diseases, can be treated more easily with innovative medicated pet food.
Other EU institutions, including the European Parliament and the Council, will consider the Commission’s proposals and will adopt their positions in due course, in accordance with the co-decision procedure.
For more information:
Commissioner Borg's website:
Follow us on Twitter: @EU_Health
Frédéric Vincent (+32 2 298 71 66)
Aikaterini Apostola (+32 2 298 76 24)
For the public: Europe Direct by phone 00 800 6 7 8 9 10 11 or by email
Latest News from
Sahel and Central Africa: €210 million in EU humanitarian aid12/05/2021 09:25:00
The EU is reaffirming its solidarity with vulnerable people in countries in the Sahel and Central Africa through a humanitarian budget of €210 million in 2021.
Security and defence: EU to move forward on common security and defence11/05/2021 15:25:00
The Council yesterday approved conclusions affirming its determination to move forward on implementing the EU's security and defence agenda, enabling the EU to take more responsibility for its own security.
Trade of dual-use items: new EU rules adopted11/05/2021 13:25:00
The EU has upgraded its legislation on the export controls applicable to sensitive dual-use goods and technologies such as cyber-surveillance tools.
Conference on the Future of Europe: make your voice heard10/05/2021 15:25:00
Conference on the Future of Europe: make your voice heard.
Porto Social Summit: all partners commit to 2030 social targets10/05/2021 13:25:00
Partners have signed up to the three 2030 headline targets set in the Commission's European Pillar of Social Rights Action Plan in a joint Porto Social Commitment.
Speech by Vice-President Jourová at Riga StratCom Dialogue 202110/05/2021 12:38:00
Speech given recently (06 May 2021) by Vice-President Jourová at Riga StratCom Dialogue 2021.
Remarks by Commissioner Stella Kyriakides at the press conference on the EU Strategy for the development and availability of therapeutics10/05/2021 09:25:00
Remarks given recently (06 May 2021) by Commissioner Stella Kyriakides at the press conference on the EU Strategy for the development and availability of therapeutics.
PESCO: Canada, Norway and the United States will be invited to participate in the project Military Mobility07/05/2021 15:25:00
Following the requests of Canada, Norway and the United States of America to participate in the PESCO project Military Mobility, the Council yesterday adopted positive decisions authorising the coordinator of this project – the Netherlands – to invite the three countries. Canada, Norway and the United States of America will be the first third states to be invited to participate in a PESCO project.
Coronavirus: Commission proposes EU Strategy for the development and availability of therapeutics07/05/2021 13:25:00
The European Commission yesterday complemented the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID'.